Focus: Genomenon is a small biotech specialist in evidence-based genomics focused on oncology applications. The company operates as a pre-revenue or early-stage entity with 1-50 employees based in Ann Arbor, Michigan.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Stable — net -1 jobs in 30d
2 added, 3 removed. Backfill posture.
Genomenon is a high-risk, high-upside pre-revenue play best suited for early-career scientists or specialists seeking equity upside and hands-on experience, not stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Genomenon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Genomenon's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles